Open AccessClinical, Dopaminergic, and Metabolic Correlations in Parkinson Disease
Author(s) -
FengTao Liu,
Jingjie Ge,
Jianjun Wu,
Ping Wu,
Yilong Ma,
Chuantao Zuo,
Jian Wang
Publication year - 2018
Publication title -
clinical nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.637
H-Index - 57
eISSN - 1536-0229
pISSN - 0363-9762
DOI - 10.1097/rlu.0000000000002148
Subject(s) - dopaminergic , parkinson's disease , medicine , neuroimaging , neuroscience , dopamine , disease , psychology , psychiatry
Neuroimaging indicators of Parkinson disease have been developed and applied in clinical practices. Dopaminergic imaging reflects nigrostriatal dopaminergic dysfunction, and metabolic network imaging offers disease-related metabolic changes at a system level. We aimed to elucidate the association between Parkinsonian symptoms and neuroimaging, and interactions between different imaging techniques.